ReviewAmerican journal of hematology2024

Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions.

Jeremy W Jacobs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.